Epirubicin hydrochloride
- CAS No.
- 56390-09-1
- Chemical Name:
- Epirubicin hydrochloride
- Synonyms
- Ebewe;Adrial;Ellence;CS-1396;Epirubin HCI;Farmorubicin-RTU;Epirubicin Ebewe;EpirubicinHc,LEp5,;Epirubicin HCl API;(8s-cis)-rochlorid
- CBNumber:
- CB3501568
- Molecular Formula:
- C27H30ClNO11
- Molecular Weight:
- 579.9802
- MDL Number:
- MFCD00274554
- MOL File:
- 56390-09-1.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| Epirubicin hydrochloride ≥90% (HPLC) | E9406 | 5mg | $238 |
| Epirubicin hydrochloride European Pharmacopoeia (EP) Reference Standard | E0550000 | 100 mg | $175 |
| Epirubicin hydrochloride British Pharmacopoeia (BP) Reference Standard | BP992 | 100MG | $239 |
| Epirubicin hydrochloride United States Pharmacopeia (USP) Reference Standard | 1237382 | 200mg | $1240 |
| Epirubicin (hydrochloride) ≥98% | 12091 | 5mg | $57 |
| More product size | |||
| Melting point | 185°C dec. |
|---|---|
| alpha | D20 +274° (c = 0.01 in methanol) |
| RTECS | QI9295750 |
| Flash point | 443.8℃ |
| storage temp. | Inert atmosphere,Store in freezer, under -20°C |
| solubility | Soluble in DMSO to 100mM, or in ethanol to 10mM |
| form | powder |
| color | red to deep red |
| Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or distilled water may be stored at -20° for up to 3 months. |
| InChIKey | MWWSFMDVAYGXBV-UAOJCOQHSA-N |
| SMILES | C12=C(O)C3=C(C(=O)C4=C(C3=O)C=CC=C4OC)C(O)=C1[C@@]([H])(O[C@H]1O[C@@H](C)[C@H](O)[C@@H](N)C1)C[C@](O)(C(=O)CO)C2.Cl |
| NCI Dictionary of Cancer Terms | Ellence; epirubicin hydrochloride |
| FDA UNII | 22966TX7J5 |
| NCI Drug Dictionary | Ellence |
| UNSPSC Code | 51102829 |
| NACRES | NA.85 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() ![]() GHS07,GHS08 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H302-H340-H350-H360 | |||||||||
| Precautionary statements | P201-P301+P312+P330-P308+P313 | |||||||||
| PPE | dust mask type N95 (US), Eyeshields, Gloves | |||||||||
| Hazard Codes | Xn | |||||||||
| Risk Statements | 22-63-62-46-40 | |||||||||
| Safety Statements | 36/37/38-45-46 | |||||||||
| WGK Germany | 3 | |||||||||
| HS Code | 29419090 | |||||||||
| Storage Class | 6.1C - Combustible acute toxic Cat.3 toxic compounds or compounds which causing chronic effects |
|||||||||
| Hazard Classifications | Acute Tox. 4 Oral Carc. 1B Muta. 1B Repr. 1B |
|||||||||
| NFPA 704 |
|
Epirubicin hydrochloride price More Price(63)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | E9406 | Epirubicin hydrochloride ≥90% (HPLC) | 56390-09-1 | 5mg | $238 | 2026-03-19 | Buy |
| Sigma-Aldrich | E0550000 | Epirubicin hydrochloride European Pharmacopoeia (EP) Reference Standard | 56390-09-1 | 100 mg | $175 | 2026-03-19 | Buy |
| Sigma-Aldrich | BP992 | Epirubicin hydrochloride British Pharmacopoeia (BP) Reference Standard | 56390-09-1 | 100MG | $239 | 2026-03-19 | Buy |
| Sigma-Aldrich | 1237382 | Epirubicin hydrochloride United States Pharmacopeia (USP) Reference Standard | 56390-09-1 | 200mg | $1240 | 2026-03-19 | Buy |
| Cayman Chemical | 12091 | Epirubicin (hydrochloride) ≥98% | 56390-09-1 | 5mg | $57 | 2024-03-01 | Buy |
Epirubicin hydrochloride Chemical Properties,Uses,Production
Description
Epirubicin hydrochloride is an antitumor antibiotic which is epimeric with doxorubicin a t the 4’-position of the amino sugar moiety. It has shown utility in the treatment of mammary, gastric, colorectal, pulmonary and ovarian carcinomas, as well as malignant lymphoma and melanoma and soft tissue sarcoma. It is reported to be less sardiotoxic than doxorubicin.
Description
Epirubicin is a stereoisomer of the antitumor anthracycline doxorubicin that undergoes β-
Chemical Properties
Orange-Red Crystalline Solid
Originator
Erbamont (Italy)
Uses
Cell-permeable anthracycline anti-tumor antibiotic
Uses
Used as an antineoplastic
brand name
Ellence(Pfizer);FARMORUBICIN.
Biological Functions
This stereoisomer of doxorubicin has the 4′-hydroxy group of the daunosamine sugar oriented in the β-position . Epirubicin will be slowly reduced to the active C13 alcohol (epirubicinol), giving it a 30- to 38-hour half life, which is similar to that of doxorubicin. Unlike doxorubicinol, however, which was equally active with doxorubicin, epirubicinol has only one-tenth the activity of its parent drug and is not believed to contribute significantly to the therapeutic action of this agent.
Biological Activity
Antibiotic antitumor agent. Inhibits the synthesis and function of DNA (IC 50 = 62.7 μ M in rat glioblastoma cell lines) and inhibits the relaxing property of topoisomerase II.
Clinical Use
Epirubicin is indicated for use in breast cancer, and the starting dose is 100 to 120 mg/m2 (compared to a starting dose of 60–75 mg/m2 for doxorubicin).
Side effects
The side effects and precautions are as outlined previously for doxorubicin, although there is a lower risk of serious myocardial toxicity or myelotoxicity.
Drug interactions
Potentially hazardous interactions with other drugsAntipsychotics: avoid with clozapine - increased risk of agranulocytosis.Ciclosporin: increased risk of neurotoxicityCytotoxics: possible increased risk of cardiotoxicity with trastuzumab - avoid for up to 28 weeks after stopping trastuzumab.Ulcer-healing drugs: concentration increased by cimetidine. Vaccines: avoid with live vaccines
Metabolism
Cleavage of the epimerized sugar will occur before excretion, generating an aglycone that is indistinguishable from that generated by doxorubicin. Although excretion is primarily biliary, dosage reduction in severe renal impairment, as well as in hepatic dysfunction, is warranted.
storage
+4°C
References
[1] R J CERSOSIMO W K H. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.[J]. Journal of Clinical Oncology, 1986, 4 3: 425-439. DOI:10.1200/jco.1986.4.3.425
[2] S SPADARI. DNA polymerases and DNA topoisomerases as targets for the development of anticancer drugs.[J]. Anticancer research, 1986, 6 5: 935-940.
[3] GIORGIO MINOTTI. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.[J]. Pharmacological Reviews, 2004, 56 2: 185-229. DOI:10.1124/pr.56.2.6
[4] GIUSEPPE MERCURO. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.[J]. Oncologist, 2007, 12 9: 1124-1133. DOI:10.1634/theoncologist.12-9-1124
Epirubicin hydrochloride Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hebei Kangcang new material Technology Co., LTD | +8615713292910 | Nancy@kangcang.com.cn | China | 341 | 58 |
| Hebei Chuanghai Biotechnology Co., Ltd | +8615350571055 | Sibel@chuanghaibio.com | China | 8738 | 58 |
| BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. | +86-18600796368 | sales@sjar-tech.com | China | 529 | 58 |
| Shandong Xuhuang New material CoLTD | +86-15095020839 +86-17660422208 | China | 726 | 58 | |
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | info@tianfuchem.com | China | 21591 | 55 |
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 33024 | 60 |
| career henan chemical co | +86-0371-86658258 +8613203830695 | sales@coreychem.com | China | 29820 | 58 |
| Biochempartner | 0086-13720134139 | candy@biochempartner.com | CHINA | 965 | 58 |
| Xiamen AmoyChem Co., Ltd | +86-86-5926051114 +8615060885618 | sales@amoychem.com | China | 6369 | 58 |
| HubeiwidelychemicaltechnologyCo.,Ltd | 18627774460 | faith@widelychemical.com | CHINA | 742 | 58 |
Related articles
- Epirubicin hydrochloride: Pharmacodynamic,Pharmacokinetic Properties and its application
- The anthracycline family drug epirubicin hydrochloride is widely used in the therapy of lymphoma,leukemia, and sarcoma. Its re....
- Dec 15,2025
View Lastest Price from Epirubicin hydrochloride manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-04-28 | Epirubicin hydrochloride
56390-09-1
|
0.99 | RongNa Biotechnology Co.,Ltd | ||||
![]() |
2026-04-28 | Epirubicin Hydrochloride
56390-09-1
|
US $0.00 / g | 1g | More Than 99% | 100kg/Month | BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. | |
![]() |
2026-04-28 | Epirubicin Hydrochloride.
56390-09-1
|
US $0.00 / g | 1g | More Than 99% | 100kg/Month | BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. |
-

- Epirubicin hydrochloride
56390-09-1
- 0.99
- RongNa Biotechnology Co.,Ltd
-

- Epirubicin Hydrochloride
56390-09-1
- US $0.00 / g
- More Than 99%
- BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
-

- Epirubicin Hydrochloride.
56390-09-1
- US $0.00 / g
- More Than 99%
- BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.






